Version françaiseEnglish version
RD Biotech / Molecular biology / Biologie MoléculaireRD Biotech / Services analytiques / Analytical servicesRD Biotech / Anticorps monoclonaux (mAb) / Monoclonal antibodiesRD Biotech / ELISARD Biotech / Culture Cellulaire / Cell cultureRD Biotech / Production de cellules / Cell production



3 rue Henri Baigue

F-25000 Besançon

+33(0)3 81 53 88 37

Biotech Investissement

RD-BIOTECH is now a sister company of DIACLONE and SYNABS, for a better synergy in the field of monoclonal antibodies!

Read more

Careers with RD Biotech

Please apply using the online application form


News from RD-Biotech

RD-Biotech, Diaclone and the mAbexperts Group will be present at the “Inflamed Cells” day in Pasteur Institute – Paris, March 15, 2019

We will be happy to meet you to present our services & products, and especially our new custom services in Antibody Engineering: mAb sequencing, Development and Production of recombinant antibodies, Humanization Services and Phage Display.
We look forward to seeing you in Paris!
Do not hesitate to contact us at

QVQ joins the Biotech Investissement Group

We are pleased to announce that QVQ, a company based in Utrecht (The Netherlands), is now a sister company of RD-Biotech SAS, Diaclone SAS and SynAbs SA (Biotech Investissement Group –

QVQ has strong expertise in the development and production of single domain antibodies derived from llamas, which are referred to as VHHs. VHHs have unique biochemical properties due to their small size and high stability which make them very useful for tumour targeting particularly in imaging technologies and companion diagnostics. QVQ offers multiple services related to development, reformatting and optimization of VHHs with respect to stability, production levels and humanization. Besides contract research and services, QVQ has developed a growing portfolio of proprietary detection/imaging VHHs directed against targets in disease related with oncology, age disease and infectious diseases.

By joining the Biotech Investissement group, QVQ will complement the high level of expertise already present within the group, to develop and market new high-quality diagnostic assays and imaging products.

Please do not hesitate to get in touch if you require information about the QVQ products and services.

New: Recombinant antibody platform! A expert team at your service for a complete service!

From the generation of hybridomas, to the production and purification of monoclonal antibodies from a few mg to several grams.
Sequencing of your monoclonal antibodies, chimerization, humanization and production.
Phage display technology.
Characterization and validation of specificity: affinity, bioactivity ... (ELISA, Octet, Cytometry, bioassays...)
Contact us!

Please come visit the new website of our Biotech Investissement Group:

Be welcome, have a closer look at and at the news concerning our sister companies Diaclone ( and Synabs (